Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.92

-1.4%

12:57 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (17411)	3/14/1998 11:58:00 AM
From: Henry Niman	Read Replies (1) of 32384

Looks like LGND is continuing to expand clinical trials. I just ran across a combo using Targretin with chemo for previously untreated patients: L1069-18 PHASE 1-2 TRIAL OF TARGRETIN (LGD 1069) ORAL CAPSULES IN COMBINATION CHEMOTHERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER This is in addition to the Phase II/III maintenance trial for patients with advanced refractory disease: NSCLC-MAINTENANCE - L1069-20 PHASE 2/3 PLACEBO CONTROLLED TRIAL OF TARGRETIN CAPSULES (LGD1069) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next